Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18400187 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Latency in Pulmonary Tuberculosis
Condition: Pulmonary Tuberculosis
Intervention: Drug: Moxifloxacin, Isoniazid, Rifampicin Pyrazinamide, Ethambutol

Study has passed its completion date and status has not been verified in more than two years.